Dr. Theofanis Chatzistamatiou is a scientist specializing in cellular therapies and immunogenetics, with fifteen years of experience in production, quality management, and research and development of cellular therapy products (hematopoietic stem cell transplantation and Advanced Therapy Medicinal Products) within clinical laboratories and biotechnology enterprises. Since 2019, he has served as Scientific Associate at the Hellenic Cord Blood Bank, Biomedical Research Foundation of the Academy of Athens, responsible for strategic planning and organization of the Histocompatibility and Immunogenetics laboratory according to EFI and ISO standards, and for clinical studies involving Advanced Therapy Medicinal Products. He previously served as Director of the Dubai Cord Blood and Research Centre, Dubai Health Authority (2016–2018). He holds a Ph.D. in Cell Biology (2015, National and Kapodistrian University of Athens) and a Maitrise in Biochemistry (2003, Université Louis Pasteur, Strasbourg). He has authored numerous peer-reviewed publications and book chapters, and is a member of the Hellenic Society of Immunology, ISCT, and AABB.